Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Amylyx Pharmaceuticals, Inc. (AMLX)

Bedrosian Camille L — Chief Medical Officer
Mar 2, 2026
Sale
Shares
6,461
Price
$14.58
Total Value
$94.21K
Shares Held After
169,295
% of Holdings
3.7%

Amylyx Pharmaceuticals, Inc. (AMLX)

Mazzariello Gina — Chief Legal Officer
Mar 2, 2026
Sale
Shares
6,844
Price
$14.52
Total Value
$99.38K
Shares Held After
134,430
% of Holdings
4.8%
Mar 2, 2026
Sale
Shares
9,100
Price
$42.49
Total Value
$386.66K
Shares Held After
642,540
% of Holdings
1.4%
Mar 2, 2026
Sale
Shares
5,900
Price
$41.73
Total Value
$246.21K
Shares Held After
651,640
% of Holdings
0.9%

GENELUX Corp (GNLX)

Thomas John — Director
Mar 2, 2026
Sale
Shares
10,000
Price
$2.90
Total Value
$28.96K
Shares Held After
482,784
% of Holdings
2.0%

Ultragenyx Pharmaceutical Inc. (RARE)

Harris Erik — EVP & Chief Commercial Officer
Mar 2, 2026
Sale
Shares
10,539
Price
$22.80
Total Value
$240.29K
Shares Held After
89,515
% of Holdings
10.5%
Mar 2, 2026
Sale
Shares
54,404
Price
$22.80
Total Value
$1.24M
Shares Held After
658,994
% of Holdings
7.6%

Krystal Biotech, Inc. (KRYS)

ROMANO KATHRYN — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
750
Price
$267.60
Total Value
$200.70K
Shares Held After
22,366
% of Holdings
3.2%
Mar 2, 2026
Sale
Shares
200
Price
$9.98
Total Value
$2.00K
Shares Held After
1,122,391
% of Holdings
0.0%
Mar 2, 2026
Sale
Shares
21,800
Price
$9.50
Total Value
$207.19K
Shares Held After
1,122,591
% of Holdings
1.9%

FibroBiologics, Inc. (FBLG)

Davis Jason — Chief Financial Officer
Mar 2, 2026
Purchase
Shares
70,000
Price
$0.41
Total Value
$28.97K
Shares Held After
70,000
% of Holdings
100.0%
Mar 2, 2026
Purchase
Shares
50,000
Price
$32.96
Total Value
$1.65M
Shares Held After
54,281
% of Holdings
92.1%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Mar 2, 2026
Sale
Shares
8,148
Price
$15.44
Total Value
$125.79K
Shares Held After
34,601
% of Holdings
19.1%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Mar 2, 2026
Sale
Shares
2,675
Price
$33.81
Total Value
$90.44K
Shares Held After
237,584
% of Holdings
1.1%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Mar 2, 2026
Sale
Shares
2,325
Price
$33.28
Total Value
$77.39K
Shares Held After
240,259
% of Holdings
1.0%

Contineum Therapeutics, Inc. (CTNM)

Lorrain Daniel S. — Chief Scientific Officer
Mar 2, 2026
Sale
Shares
4,170
Price
$15.01
Total Value
$62.59K
Shares Held After
151,882
% of Holdings
2.7%

Contineum Therapeutics, Inc. (CTNM)

Watkins Tim — CMO & Head of Development
Mar 2, 2026
Sale
Shares
3,611
Price
$15.02
Total Value
$54.22K
Shares Held After
0
% of Holdings
100.0%
Version: v26.3.33